Library
PubMed
research article
Professional

The Causal Association between Plasma Metabolites-Mediated Immune Cells and Myocardial Infarction: A Mendelian Randomization Study.

Source: PubMed, NCBI / U.S. National Library of Medicine

Arquivos brasileiros de cardiologiaLiu Yue, Chen Xing, Liu Yingzhi, et al.Published 1/1/2026Last synced 6/10/2026Status: syncedPMID: 42233835DOI: 10.36660/abc.20250026

blaMyocardial infarction (MI), as an acute cardiovascular event, has been shown in previous studies to be associated with immune responses and metabolites. However, the causal relationship between immune cells and MI, as well as the mediating role of plasma metabolites, has not been clearly confirmed. Systematic analysis of the causal association between 731 immune cells and MI, as well as the mediating roles of 1400 plasma metabolites. Bidirectional Mendelian randomization (MR) analysis was used to explore the causal relationship between immune cells and MI, and one-step and two-step mediation analyses were performed to identify plasma metabolites. The analysis methods included inverse variance weighted (p<0.05), weighted median (p<0.05), simple mode (p<0.05), weighted mode (p<0.05), MR-Egger regression (p<0.05), MR-Egger intercept (p>0.05) and MR-PRESSO (p>0.05) to assess the reliability of the results. SNPs associated with immune cells and metabolites were subjected to gene selection using the STRING database, followed by enrichment analysis. A total of 44 immune cells were identified to have a causal association with MI (p<0.05), among which HLA DR on Dendritic Cell (ebi-a-GCST90002106) showed the strongest significance (p<0.001). A total of 19 SNPs were identified (OR=1.038, 95% CI 1.018-1.059). Reverse analysis showed no statistical significance (p>0.05). Plasma metabolites, including Deoxycholic acid glucuronide levels, Phosphate to N-acetylneuraminate ratio, and Glyco

Abstract

blaMyocardial infarction (MI), as an acute cardiovascular event, has been shown in previous studies to be associated with immune responses and metabolites. However, the causal relationship between immune cells and MI, as well as the mediating role of plasma metabolites, has not been clearly confirmed. Systematic analysis of the causal association between 731 immune cells and MI, as well as the mediating roles of 1400 plasma metabolites. Bidirectional Mendelian randomization (MR) analysis was used to explore the causal relationship between immune cells and MI, and one-step and two-step mediation analyses were performed to identify plasma metabolites. The analysis methods included inverse variance weighted (p<0.05), weighted median (p<0.05), simple mode (p<0.05), weighted mode (p<0.05), MR-Egger regression (p<0.05), MR-Egger intercept (p>0.05) and MR-PRESSO (p>0.05) to assess the reliability of the results. SNPs associated with immune cells and metabolites were subjected to gene selection using the STRING database, followed by enrichment analysis. A total of 44 immune cells were identified to have a causal association with MI (p<0.05), among which HLA DR on Dendritic Cell (ebi-a-GCST90002106) showed the strongest significance (p<0.001). A total of 19 SNPs were identified (OR=1.038, 95% CI 1.018-1.059). Reverse analysis showed no statistical significance (p>0.05). Plasma metabolites, including Deoxycholic acid glucuronide levels, Phosphate to N-acetylneuraminate ratio, and Glycosyl ceramide, played a mediating role in immune cells and MI, with mediation effects of 7.0%, 4.6%, and 6.6%, respectively. STRING database analysis identified eight key genes and one signaling pathway that potentially link the immune phenotypes and the three metabolites (p< 0.05). This study identified a causal relationship between immune cells and MI. The metabolites Deoxycholic acid glucuronide levels, Phosphate to N-acetylneuraminate ratio, and Glycosyl ceramide played a partial mediating role in this causal relationship.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.